Becton Dickinson (BDX) EVP Michael Garrison sells 1,100 shares in open market

Rhea-AI Filing Summary

Becton Dickinson & Co executive Michael David Garrison reported an open-market sale of company stock. On June 10, 2026, he sold 1,100 shares of Common Stock at an average price of $151.48 per share. After this transaction, he directly holds 14,272 shares. A footnote explains that his direct holdings reflect prior adjustments tied to the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp., which affected the number of shares underlying previously reported, unvested time-vested restricted stock units.

Insider Trade Summary 10b5-1

Net Seller: 1,100 shares ($166,628)

Net Sell 1 txn

Insider Garrison Michael David

Role EVP & Pres Med.Essntl&BioPharm

Sold 1,100 shs ($167K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,100	$151.48	$167K

Holdings After Transaction: Common Stock — 14,272 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 1,100 shares Sale price: $151.48 per share Shares held after transaction: 14,272 shares +1 more

4 metrics

Shares sold 1,100 shares Open-market sale on June 10, 2026

Sale price $151.48 per share Average price for the reported sale

Shares held after transaction 14,272 shares Direct Common Stock holdings post-sale

Net buy/sell shares -1,100 shares Net-sell direction in transaction summary

Key Terms

open-market sale, restricted stock units, Common Stock, Form 4

4 terms

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

restricted stock units financial

"unvested time-vested restricted stock units held by the reporting person"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Garrison Michael David

(Last) (First) (Middle)

C/O BECTON, DICKINSON AND COMPANY

1 BECTON DRIVE

(Street)

FRANKLIN LAKES NEW JERSEY 07417

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BECTON DICKINSON & CO [ BDX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Pres Med.Essntl&BioPharm

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		S		1,100	D	$151.48	14,272(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

Remarks:

The reported transactions were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 18, 2026.

	Donna Kalazdy, by power of attorney from Michael David Garrison	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Becton Dickinson (BDX) report for Michael David Garrison?

Becton Dickinson executive Michael David Garrison reported an open-market sale of 1,100 shares of Common Stock at an average price of $151.48 per share on June 10, 2026, according to the Form 4 insider filing.

What is Michael David Garrison’s role at Becton Dickinson (BDX)?

Michael David Garrison is an executive officer at Becton Dickinson, serving as EVP & President, Medical Essential and BioPharm. His position indicates a senior leadership role, making his equity transactions relevant for tracking executive ownership and alignment with shareholders.

How many Becton Dickinson (BDX) shares does Michael David Garrison hold after this sale?

After selling 1,100 shares, Michael David Garrison directly holds 14,272 shares of Becton Dickinson Common Stock. This post-transaction balance, disclosed in the Form 4, shows he retains a meaningful equity stake in the company following the reported sale.

Was the Becton Dickinson (BDX) insider sale an open-market transaction?

Yes. The Form 4 identifies the transaction as an open-market sale of Common Stock, with a transaction code “S” and description indicating a sale in open market or private transaction at an average price of $151.48 per share.

What does the Waters Corp. footnote mean in the Becton Dickinson (BDX) Form 4?

The footnote states that Garrison’s direct holdings reflect adjustments from combining the Biosciences and Diagnostic Solutions businesses with Waters Corp., changing the number of shares underlying his previously reported, unvested time-vested restricted stock units, without altering the nature of the current open-market sale.